Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Bruker Cellular Analysis, Inc.CELL · Entity 109250 | Director | October 02, 2023 | October 03, 2023 |
| Catalent, Inc.CTLT · Entity 16279 | Director · Executive Chair | August 24, 2022 | August 27, 2022 |
| QuidelOrtho CorpQDEL · Entity 4986 | Director | June 25, 2026 | June 29, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Bruker Cellular Analysis, Inc.
Report date October 02, 2023 · Filed October 03, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2023-10-02 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2023-10-02 · Disposition to issuer · Disposed 71,225 · Balance 41,240 F1: On October 2, 2023, pursuant to the Agreement and Plan of Merger dated as of August 17, 2023 (the "Merger Agreement"), by and among Bruker Corporation ("Bruker"), Bird Mergersub Corporation ("Merger Sub") and Phenomex Inc. (the "Company"), Merger Sub merged with and into the Company, with the Company surviving the Merger as a wholly owned subsidiary of Bruker (the "Merger"), and each restricted stock unit ("RSU") held by the Reporting Person was cancelled and converted into the right to receive $1.00 per share in cash (the "Merger Consideration"). F2: Pursuant to the Merger, the Reporting Person disposed of each RSU held by him in exchange for the Merger Consideration. Row 2 · 2023-10-02 · Disposition to issuer · Disposed 41,240 · Balance 0 F3: Pursuant to the Merger Agreement, each outstanding share of Common Stock, par value $0.00005 per share ("Common Stock") held by the Reporting Person was cancelled and converted into the right to receive the Merger Consideration. F4: Pursuant to the Merger, the Reporting Person disposed of all shares of Common Stock beneficially owned by him in exchange for the Merger Consideration. |
Filing footnotes · ownership attribution and instrument terms
F1: On October 2, 2023, pursuant to the Agreement and Plan of Merger dated as of August 17, 2023 (the "Merger Agreement"), by and among Bruker Corporation ("Bruker"), Bird Mergersub Corporation ("Merger Sub") and Phenomex Inc. (the "Company"), Merger Sub merged with and into the Company, with the Company surviving the Merger as a wholly owned subsidiary of Bruker (the "Merger"), and each restricted stock unit ("RSU") held by the Reporting Person was cancelled and converted into the right to receive $1.00 per share in cash (the "Merger Consideration").
F2: Pursuant to the Merger, the Reporting Person disposed of each RSU held by him in exchange for the Merger Consideration.
F3: Pursuant to the Merger Agreement, each outstanding share of Common Stock, par value $0.00005 per share ("Common Stock") held by the Reporting Person was cancelled and converted into the right to receive the Merger Consideration.
F4: Pursuant to the Merger, the Reporting Person disposed of all shares of Common Stock beneficially owned by him in exchange for the Merger Consideration.
Catalent, Inc.
Report date August 24, 2022 · Filed August 27, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 229,888 |
Last balance in matching sequence
After 2022-08-25 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2022-08-24 · Grant · Acquired 99,275 · Balance 268,822 F1: Received upon the achievement of the fiscal 2020-22 performance-based vesting criteria set forth in certain incentive compensation held by the reporting person under the Issuer's long-term incentive plan. F2: Includes restricted stock units. Row 2 · 2022-08-25 · Sale · Disposed 38,934 · Balance 229,888 F3: Shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of performance share units received pursuant to the Issuer's long-term incentive plan. No shares were withheld by or surrendered to the Issuer. F2: Includes restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Received upon the achievement of the fiscal 2020-22 performance-based vesting criteria set forth in certain incentive compensation held by the reporting person under the Issuer's long-term incentive plan.
F2: Includes restricted stock units.
F3: Shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of performance share units received pursuant to the Issuer's long-term incentive plan. No shares were withheld by or surrendered to the Issuer.
QuidelOrtho Corp
Report date June 25, 2026 · Filed June 29, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock Units (Equity Grant)SEC Table II · derivative / convertible security | Direct | 15,532 |
Reported balance
After 2026-06-25 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-25 · Grant · Acquired 15,532 · Balance 15,532 F1: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2: The restricted stock units will vest on June 25, 2027. |
| Restricted Stock Units (Converted)SEC Table II · derivative / convertible security | Direct | 5,547 |
Reported balance
After 2026-06-25 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-06-25 · Grant · Acquired 5,547 · Balance 5,547 F1: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F4: 1,386 shares vested on June 25, 2026, 1,387 shares will vest on September 25, 2026, 1,387 shares will vest on December 25, 2026, and 1,387 shares will vest on March 25, 2027. |
| Restricted Stock Units (Premium)SEC Table II · derivative / convertible security | Direct | 1,109 |
Reported balance
After 2026-06-25 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-06-25 · Grant · Acquired 1,109 · Balance 1,109 F1: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2: The restricted stock units will vest on June 25, 2027. F3: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
F2: The restricted stock units will vest on June 25, 2027.
F3: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule.
F4: 1,386 shares vested on June 25, 2026, 1,387 shares will vest on September 25, 2026, 1,387 shares will vest on December 25, 2026, and 1,387 shares will vest on March 25, 2027.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 12, 2018 Filed Sep 14, 2018 15:57 UTC | Catalent, Inc. CTLT · Entity 16279 | GiftCommon Stock | 2,434 | $0.00 | $0.00 |
DisclosureSEC source: 0001596783-18-000146 · wf-form4_153694062911409.xml · nonDerivative · entry 1 Chiminski John R · CIK 0001482197 · Director · Chair, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 275,919 Read SEC document |
| August 27, 2018 Filed Aug 29, 2018 20:46 UTC | Catalent, Inc. CTLT · Entity 16279 | Tax withholdingCommon Stock | 9,783 | $43.66 | $427,125.78 |
DisclosureSEC source: 0001596783-18-000113 · wf-form4_153557558804897.xml · nonDerivative · entry 1 Chiminski John R · CIK 0001482197 · Director · Chair, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 297,919 F1 · balance_after: Includes restricted stock units. Read SEC document |
| August 27, 2018 Filed Sep 4, 2018 23:48 UTC Amendment | Catalent, Inc. CTLT · Entity 16279 | Tax withholdingCommon Stock | 9,783 | $43.66 | $427,125.78 |
DisclosureSEC source: 0001596783-18-000133 · wf-form4a_153610491595972.xml · nonDerivative · entry 1 Chiminski John R · CIK 0001482197 · Director · Chair, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 278,353 F1 · acquired: The original Form 4, filed on August 29, 2018, is being amended by this Form 4 amendment to correct a clerical error, which misreported a disposition of shares in connection with vesting-related tax withholding as an acquisition in column 4 of Table I. The reporting person's holdings in column 5 of Table I are also adjusted to reflect this correction. F1 · balance_after: The original Form 4, filed on August 29, 2018, is being amended by this Form 4 amendment to correct a clerical error, which misreported a disposition of shares in connection with vesting-related tax withholding as an acquisition in column 4 of Table I. The reporting person's holdings in column 5 of Table I are also adjusted to reflect this correction. F2 · balance_after: Includes restricted stock units. Read SEC document |
| August 23, 2018 Filed Aug 27, 2018 21:19 UTC | Catalent, Inc. CTLT · Entity 16279 | Tax withholdingCommon Stock | 17,561 | $41.83 | $734,576.63 |
DisclosureSEC source: 0001596783-18-000087 · wf-form4_153540476127611.xml · nonDerivative · entry 2 Chiminski John R · CIK 0001482197 · Director · Chair, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 288,136 F2 · balance_after: Includes restricted stock units. Read SEC document |
| August 23, 2018 Filed Aug 27, 2018 21:19 UTC | Catalent, Inc. CTLT · Entity 16279 | GrantCommon Stock | 48,610 | $0.00 | $0.00 |
DisclosureSEC source: 0001596783-18-000087 · wf-form4_153540476127611.xml · nonDerivative · entry 1 Chiminski John R · CIK 0001482197 · Director · Chair, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 305,697 F1 · kind: Received upon the achievement of the fiscal 2016-18 performance-based vesting criteria set forth in certain performance share units held by the reporting person. F2 · balance_after: Includes restricted stock units. Read SEC document |
| July 23, 2018 Filed Jul 25, 2018 17:43 UTC | Catalent, Inc. CTLT · Entity 16279 | GrantOptions to purchase Common Stock · Derivative | 138,543 | $0.00 Strike: $43.88 | $0.00 |
DisclosureSEC source: 0001596783-18-000043 · wf-form4_153254057071842.xml · derivative · entry 2 Chiminski John R · CIK 0001482197 · Director · Chair, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,543 Underlying: Common Stock · 138,543 shares Expires 2028-07-23 F3 · shares: Received by the reporting person pursuant to the Issuer's annual grant to executive officers and other personnel under its long-term incentive plan. F4 · derivative.exercise_date: The options vest and become exercisable in four equal annual installments beginning on July 23, 2019. Read SEC document |
| July 23, 2018 Filed Jul 25, 2018 17:43 UTC | Catalent, Inc. CTLT · Entity 16279 | GrantCommon Stock | 27,006 | $0.00 | $0.00 |
DisclosureSEC source: 0001596783-18-000043 · wf-form4_153254057071842.xml · nonDerivative · entry 1 Chiminski John R · CIK 0001482197 · Director · Chair, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 257,087 F1 · shares: Restricted stock received by the reporting person pursuant to the Issuer's annual grant to executive officers and other personnel under its long-term incentive plan. Subject to forfeiture until vested on third anniversary of grant. F2 · balance_after: Includes restricted stock units. Read SEC document |
| December 12, 2017 Filed Dec 13, 2017 19:37 UTC | Catalent, Inc. CTLT · Entity 16279 | SaleCommon Stock | 78,190 | $39.51 | $3,089,286.90 |
DisclosureSEC source: 0001596783-17-000180 · wf-form4_151319383198307.xml · nonDerivative · entry 5 Chiminski John R · CIK 0001482197 · Director · Chair, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 230,081 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2017 in order to implement a plan of financial diversification. F6 · price: Weighted average price. These shares were sold in multiple transactions at prices ranging from $39.21 to $39.86, inclusive. F2 · balance_after: Includes restricted stock units. Read SEC document |
| December 11, 2017 Filed Dec 13, 2017 19:37 UTC | Catalent, Inc. CTLT · Entity 16279 | Exercise / conversionOptions to purchase Common Stock · Derivative | 206,685 | $0.00 Strike: $10.71 | $0.00 |
DisclosureSEC source: 0001596783-17-000180 · wf-form4_151319383198307.xml · derivative · entry 6 Chiminski John R · CIK 0001482197 · Director · Chair, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 206,685 shares Expires 2019-10-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2017 in order to implement a plan of financial diversification. F7 · derivative.exercise_date: On October 23, 2009, the reporting person was granted options to purchase common stock of the Issuer, which options began to vest and become exercisable upon the passage of time (and, in certain cases, the satisfaction of performance criteria) beginning October 23, 2010. All options have vested and been exercised or have been cancelled as of the date of this Form 4. Read SEC document |
| December 11, 2017 Filed Dec 13, 2017 19:37 UTC | Catalent, Inc. CTLT · Entity 16279 | SaleCommon Stock | 21,810 | $39.70 | $865,857.00 |
DisclosureSEC source: 0001596783-17-000180 · wf-form4_151319383198307.xml · nonDerivative · entry 4 Chiminski John R · CIK 0001482197 · Director · Chair, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 308,271 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2017 in order to implement a plan of financial diversification. F5 · price: Weighted average price. These shares were sold in multiple transactions at prices ranging from $39.61 to $39.75, inclusive. F2 · balance_after: Includes restricted stock units. Read SEC document |
| December 11, 2017 Filed Dec 13, 2017 19:37 UTC | Catalent, Inc. CTLT · Entity 16279 | SaleCommon Stock | 81,458 | $39.70 | $3,233,882.60 |
DisclosureSEC source: 0001596783-17-000180 · wf-form4_151319383198307.xml · nonDerivative · entry 3 Chiminski John R · CIK 0001482197 · Director · Chair, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 330,081 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2017 in order to implement a plan of financial diversification. F4 · price: Weighted average price. These shares were sold in multiple transactions at prices ranging from $39.42 to $40.11, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (4), (5), and (6) to this Form 4. F2 · balance_after: Includes restricted stock units. Read SEC document |
| December 11, 2017 Filed Dec 13, 2017 19:37 UTC | Catalent, Inc. CTLT · Entity 16279 | Tax withholdingCommon Stock | 125,227 | $39.70 | $4,971,511.90 |
DisclosureSEC source: 0001596783-17-000180 · wf-form4_151319383198307.xml · nonDerivative · entry 2 Chiminski John R · CIK 0001482197 · Director · Chair, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 411,539 F3 · kind: Represents shares withheld to pay the exercise price and applicable withholding taxes associated with the exercise of stock options pursuant to the Rule 10b5-1 trading plan noted in footnote (1). F2 · balance_after: Includes restricted stock units. Read SEC document |
| December 11, 2017 Filed Dec 13, 2017 19:37 UTC | Catalent, Inc. CTLT · Entity 16279 | Exercise / conversionCommon Stock | 206,685 | $10.71 | $2,213,596.35 |
DisclosureSEC source: 0001596783-17-000180 · wf-form4_151319383198307.xml · nonDerivative · entry 1 Chiminski John R · CIK 0001482197 · Director · Chair, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 536,766 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2017 in order to implement a plan of financial diversification. F2 · balance_after: Includes restricted stock units. Read SEC document |
| October 23, 2017 Filed Oct 25, 2017 16:32 UTC | Catalent, Inc. CTLT · Entity 16279 | Tax withholdingCommon Stock | 3,604 | $42.74 | $154,034.96 |
DisclosureSEC source: 0001596783-17-000161 · wf-form4_150894912753019.xml · nonDerivative · entry 1 Chiminski John R · CIK 0001482197 · Director · Chair, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 330,081 Read SEC document |
| September 16, 2017 Filed Sep 18, 2017 23:53 UTC | Catalent, Inc. CTLT · Entity 16279 | Tax withholdingCommon Stock | 22,039 | $39.49 | $870,320.11 |
DisclosureSEC source: 0001596783-17-000156 · wf-form4_150577876695207.xml · nonDerivative · entry 1 Chiminski John R · CIK 0001482197 · Director · Chair, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 333,685 Read SEC document |
| August 24, 2017 Filed Aug 28, 2017 16:26 UTC | Catalent, Inc. CTLT · Entity 16279 | Tax withholdingCommon Stock | 9,730 | $35.21 | $342,593.30 |
DisclosureSEC source: 0001596783-17-000132 · wf-form4_150393756776205.xml · nonDerivative · entry 4 Chiminski John R · CIK 0001482197 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 355,724 F2 · balance_after: Includes restricted stock units. Read SEC document |
| August 24, 2017 Filed Aug 28, 2017 16:26 UTC | Catalent, Inc. CTLT · Entity 16279 | GrantCommon Stock | 21,147 | $0.00 | $0.00 |
DisclosureSEC source: 0001596783-17-000132 · wf-form4_150393756776205.xml · nonDerivative · entry 3 Chiminski John R · CIK 0001482197 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 365,454 F1 · kind: Received upon the achievement of the fiscal 2015-17 performance-based vesting criteria set forth in certain performance share units held by the reporting person. F2 · balance_after: Includes restricted stock units. Read SEC document |
| August 24, 2017 Filed Aug 28, 2017 16:26 UTC | Catalent, Inc. CTLT · Entity 16279 | Tax withholdingCommon Stock | 9,742 | $35.21 | $343,015.82 |
DisclosureSEC source: 0001596783-17-000132 · wf-form4_150393756776205.xml · nonDerivative · entry 2 Chiminski John R · CIK 0001482197 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 344,307 F2 · balance_after: Includes restricted stock units. Read SEC document |
| August 24, 2017 Filed Aug 28, 2017 16:26 UTC | Catalent, Inc. CTLT · Entity 16279 | GrantCommon Stock | 21,173 | $0.00 | $0.00 |
DisclosureSEC source: 0001596783-17-000132 · wf-form4_150393756776205.xml · nonDerivative · entry 1 Chiminski John R · CIK 0001482197 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 354,049 F1 · kind: Received upon the achievement of the fiscal 2015-17 performance-based vesting criteria set forth in certain performance share units held by the reporting person. F2 · balance_after: Includes restricted stock units. Read SEC document |
| August 23, 2017 Filed Aug 25, 2017 16:39 UTC | Catalent, Inc. CTLT · Entity 16279 | GrantOptions to purchase Common Stock · Derivative | 61,056 | $0.00 Strike: $34.91 | $0.00 |
DisclosureSEC source: 0001596783-17-000102 · wf-form4_150367914176615.xml · derivative · entry 2 Chiminski John R · CIK 0001482197 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,056 Underlying: Common Stock · 61,056 shares Expires 2027-08-23 F3 · shares: Received by the reporting person pursuant to the Issuer's annual grant to executive officers and other personnel under its long-term incentive plan and to the reporting person's employment agreement with the Issuer. F4 · derivative.exercise_date: The options vest in four equal annual installments beginning on August 23, 2018. Read SEC document |
| August 23, 2017 Filed Aug 25, 2017 16:39 UTC | Catalent, Inc. CTLT · Entity 16279 | GrantCommon Stock | 11,602 | $0.00 | $0.00 |
DisclosureSEC source: 0001596783-17-000102 · wf-form4_150367914176615.xml · nonDerivative · entry 1 Chiminski John R · CIK 0001482197 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 332,876 F1 · security: Restricted stock received by the reporting person pursuant to the Issuer's annual grant to executive officers and other personnel under its long-term incentive plan and to the reporting person's employment agreement with the Issuer. Subject to forfeiture until vested on third anniversary of grant. F2 · balance_after: Includes restricted stock units. Read SEC document |
| July 31, 2017 Filed Aug 1, 2017 22:33 UTC | Catalent, Inc. CTLT · Entity 16279 | Tax withholdingCommon Stock | 3,816 | $34.97 | $133,445.52 |
DisclosureSEC source: 0001596783-17-000088 · wf-form4_150162679700806.xml · nonDerivative · entry 1 Chiminski John R · CIK 0001482197 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 321,274 F1 · balance_after: Includes restricted stock units. Read SEC document |
| July 24, 2017 Filed Jul 26, 2017 23:04 UTC | Catalent, Inc. CTLT · Entity 16279 | GrantOptions to purchase Common Stock · Derivative | 103,747 | $0.00 Strike: $36.02 | $0.00 |
DisclosureSEC source: 0001596783-17-000067 · wf-form4_150111028654618.xml · derivative · entry 2 Chiminski John R · CIK 0001482197 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,747 Underlying: Common Stock · 103,747 shares Expires 2027-07-24 F3 · shares: Received by the reporting person pursuant to the Issuer's annual grant to executive officers and other personnel under its long-term incentive plan. F4 · derivative.exercise_date: The options vest in four equal annual installments beginning on July 24, 2018. Read SEC document |
| July 24, 2017 Filed Jul 26, 2017 23:04 UTC | Catalent, Inc. CTLT · Entity 16279 | GrantCommon Stock | 19,989 | $0.00 | $0.00 |
DisclosureSEC source: 0001596783-17-000067 · wf-form4_150111028654618.xml · nonDerivative · entry 1 Chiminski John R · CIK 0001482197 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 325,090 F1 · shares: Restricted stock units received by the reporting person pursuant to the Issuer's annual grant to executive officers and other personnel under its long-term incentive plan. F2 · balance_after: Includes restricted stock units. Read SEC document |
| March 20, 2017 Filed Mar 20, 2017 21:31 UTC | Catalent, Inc. CTLT · Entity 16279 | SaleCommon Stock | 201 | $28.76 | $5,780.76 |
DisclosureSEC source: 0001596783-17-000025 · wf-form4_149004545856600.xml · nonDerivative · entry 5 Chiminski John R · CIK 0001482197 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,507 F4 · kind: Represents shares sold pursuant to the Rule 10b5-1 trading plan in footnote 1. F2 · balance_after: Includes restricted stock units. Read SEC document |
| March 16, 2017 Filed Mar 20, 2017 21:31 UTC | Catalent, Inc. CTLT · Entity 16279 | Exercise / conversionOptions to purchase Common Stock · Derivative | 206,684 | $10.71 Strike: $10.71 | $2,213,585.64 |
DisclosureSEC source: 0001596783-17-000025 · wf-form4_149004545856600.xml · derivative · entry 6 Chiminski John R · CIK 0001482197 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,316 Underlying: Common Stock · 206,684 shares Expires 2019-10-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 14, 2017 in order to implement a plan of financial diversification. F7 · derivative.exercise_date: On October 23, 2009, the reporting person was granted an option to purchase 472,500 shares of common stock of the Issuer, which vested and became exercisable in five equal annual installments beginning on March 17, 2010. Read SEC document |
| March 16, 2017 Filed Mar 20, 2017 21:31 UTC | Catalent, Inc. CTLT · Entity 16279 | SaleCommon Stock | 4,784 | $28.58 | $136,726.72 |
DisclosureSEC source: 0001596783-17-000025 · wf-form4_149004545856600.xml · nonDerivative · entry 4 Chiminski John R · CIK 0001482197 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,708 F4 · kind: Represents shares sold pursuant to the Rule 10b5-1 trading plan in footnote 1. F6 · price: These shares were sold in multiple transactions at prices ranging from $28.55 to $28.63, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: Includes restricted stock units. Read SEC document |
| March 16, 2017 Filed Mar 20, 2017 21:31 UTC | Catalent, Inc. CTLT · Entity 16279 | SaleCommon Stock | 68,834 | $28.62 | $1,970,029.08 |
DisclosureSEC source: 0001596783-17-000025 · wf-form4_149004545856600.xml · nonDerivative · entry 3 Chiminski John R · CIK 0001482197 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 191,492 F4 · kind: Represents shares sold pursuant to the Rule 10b5-1 trading plan in footnote 1. F5 · price: These shares were sold in multiple transactions at prices ranging from $28.45 to $28.88, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: Includes restricted stock units. Read SEC document |
| March 16, 2017 Filed Mar 20, 2017 21:31 UTC | Catalent, Inc. CTLT · Entity 16279 | Tax withholdingCommon Stock | 132,865 | $28.50 | $3,786,652.50 |
DisclosureSEC source: 0001596783-17-000025 · wf-form4_149004545856600.xml · nonDerivative · entry 2 Chiminski John R · CIK 0001482197 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,326 F3 · kind: Represents shares withheld to pay the exercise price and applicable withholding taxes associated with the exercise of stock options pursuant to the Rule 10b5-1 trading plan noted in footnote 1. F2 · balance_after: Includes restricted stock units. Read SEC document |
| March 16, 2017 Filed Mar 20, 2017 21:31 UTC | Catalent, Inc. CTLT · Entity 16279 | Exercise / conversionCommon Stock | 206,684 | $10.71 | $2,213,585.64 |
DisclosureSEC source: 0001596783-17-000025 · wf-form4_149004545856600.xml · nonDerivative · entry 1 Chiminski John R · CIK 0001482197 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 393,191 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 14, 2017 in order to implement a plan of financial diversification. F2 · balance_after: Includes restricted stock units. Read SEC document |
| September 09, 2016 Filed Sep 13, 2016 23:05 UTC | Catalent, Inc. CTLT · Entity 16279 | GrantCommon Stock · Derivative | 183,369 | $0.00 Strike: $10.71 | $0.00 |
DisclosureSEC source: 0001596783-16-000131 · wf-form4_147380794340906.xml · derivative · entry 1 Chiminski John R · CIK 0001482197 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,369 Underlying: Common Stock · 183,369 shares Expires 2019-10-23 F1 · kind: Due to the satisfaction of a market-based vesting condition, on September 9, 2016, the reporting person was issued 183,369 vested and exercisable options to purchase shares of common stock of the Issuer. Read SEC document |
| March 17, 2016 Filed Aug 25, 2017 16:29 UTC | Catalent, Inc. CTLT · Entity 16279 | Tax withholdingCommon Stock | 87,006 | $0.00 | $0.00 |
DisclosureSEC source: 0001596783-17-000101 · wf-form4_150367856147558.xml · nonDerivative · entry 1 Chiminski John R · CIK 0001482197 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 321,274 F1 · shares: Represents shares withheld to pay the applicable withholding taxes associated with the vesting of restricted stock units and the delivery of the underlying shares of common stock to the reporting person. This disposition was not reflected by the reporting person on subsequent Form 4 reports filed on July 28, 2016, September 13, 2016, and March 20, 2017. The Form 4 reports filed on July 26, 2017 and August 1, 2017 did reflect this disposition. F2 · balance_after: Includes restricted stock units. Represents the reporting person's holdings as of the filing of this Form 4 report. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.